Sunday, July 13, 2025
Distribution: (800) 510 0384
Washington DC
New York
Toronto
Press ID  
  • Login
The Hudson Weekly
  • Financial
  • Blockchain
  • Technology
  • Entertainment
  • Lifestyle
  • Arts
  • Health
  • Sports
  • Cybersecurity
No Result
View All Result
  • Financial
  • Blockchain
  • Technology
  • Entertainment
  • Lifestyle
  • Arts
  • Health
  • Sports
  • Cybersecurity
No Result
View All Result
The Hudson Weekly
No Result
View All Result

FDA Approves Treatment for Chronic Kidney Disease

Approval is First to Cover Many Causes of Disease

Craig Richer by Craig Richer
May 3, 2021
in Health
A A
FDA Accepts BioMarin’s New Drug Application for Vosoritide to Treat Children with Achondroplasia

© FDA

Share on FacebookShare on Twitter

U.S. Food and Drug Administration approved Farxiga (dapagliflozin) oral tablets to reduce the risk of kidney function decline, kidney failure, cardiovascular death and hospitalization for heart failure in adults with chronic kidney disease who are at risk of disease progression.

“Chronic kidney disease is an important public health issue, and there is a significant unmet need for therapies that slow disease progression and improve outcomes,” said Aliza Thompson, M.D., M.S., deputy director of the Division of Cardiology and Nephrology in the FDA’s Center for Drug Evaluation and Research. “Today’s approval of Farxiga for the treatment of chronic kidney disease is an important step forward in helping people living with kidney disease.”

HudsonNewsroom

Redefining Wellness Travel: A Conversation With Craig Dempsey of Medical Tourism Packages

Tips for Maintaining a Healthy Gut

Is BPD on the Psychotic Spectrum?

Chronic kidney disease occurs when the kidneys are damaged and cannot filter blood normally. Due to this defective filtering, patients can have complications related to fluid, electrolytes (minerals required for many bodily processes), and waste build-up in the body. Chronic kidney disease sometimes can progress to kidney failure. Patients also are at high risk of cardiovascular disease, including heart disease and stroke.

The efficacy of Farxiga to improve kidney outcomes and reduce cardiovascular death in patients with chronic kidney disease was evaluated in a multicenter, double-blind study. In this study, 4,304 patients were randomly assigned to receive either Farxiga or a placebo. The study compared the two groups for the number of patients whose disease progressed to a composite (or combined) endpoint that included at least a 50% reduction in kidney function, progression to kidney failure, or cardiovascular or kidney death. Results showed that 197 of the 2,152 patients who received Farxiga had at least one of the composite endpoint events compared to 312 of the 2,152 patients who received a placebo. The study also compared the two groups for the number of patients who were hospitalized for heart failure or died from cardiovascular disease. A total of 100 patients who received Farxiga were hospitalized or died compared to 138 patients who received a placebo.

Farxiga was not studied, nor is expected to be effective, in treating chronic kidney disease among patients with autosomal dominant or recessive polycystic (characterized by multiple cysts) kidney disease or among patients who require or have recently used immunosuppressive therapy to treat kidney disease.

Patients should not use Farxiga if they have a history of serious hypersensitivity reactions to the medication or if they are on dialysis treatment. Serious, life-threatening cases of Fournier’s Gangrene have occurred in patients with diabetes taking Farxiga. Patients should consider a lower dose of insulin or insulin secretagogue to reduce the risk of hypoglycemia (low blood sugar) if they are also taking Farxiga. Farxiga can cause dehydration, serious urinary tract infections, genital yeast infections, and metabolic acidosis or ketoacidosis (acid build-up in the blood). Patients should be assessed for their volume status and kidney function before starting Farxiga.

Farxiga was originally approved in 2014 to improve glycemic control in adults with type 2 diabetes in addition to diet and exercise.

Farxiga received Fast Track, Breakthrough Therapy, and Priority Review designations for the indication being approved today. Fast track is designed to facilitate the development and expedite the review of drugs to treat serious conditions and fill an unmet medical need. Breakthrough therapy designation is designed to expedite the development and review of drugs that are intended to treat a serious condition and preliminary clinical evidence indicates that the drug may demonstrate substantial improvement over available therapy on a clinically significant endpoint(s). Priority review directs overall attention and resources to the evaluation of applications for drugs that, if approved, would be significant improvements in the safety or effectiveness of the treatment, diagnosis or prevention of serious conditions when compared to standard applications.

The FDA granted the approval of Farxiga to AstraZeneca.

Craig Richer

Craig Richer

Newsroom Editor

More from HW Newsdesk

Craig Dempsey
Health

Redefining Wellness Travel: A Conversation With Craig Dempsey of Medical Tourism Packages

July 10, 2025
Tips for Maintaining a Healthy Gut
Health

Tips for Maintaining a Healthy Gut

July 10, 2025
Is BPD On The Psychotic Spectrum?
Health

Is BPD on the Psychotic Spectrum?

July 9, 2025

HW Newsroom

7 Tips for Finding the Right Personal Injury Attorney in New Jersey
Technology

SEO Tips for Personal Injury Law Firms

by Craig Richer
July 11, 2025

Personal injury firms in the U.S. are steadily increasing, reflecting the rising number of accidents, insurance disputes, and injury-related claims...

The Business Case for Off-Grid Solar: Lower Costs, Higher Resilience

The Business Case for Off-Grid Solar: Lower Costs, Higher Resilience

July 11, 2025
Mariami Taps Into Her Power on New Single 'She Rains'

What Was Once Veiled Now Reigns by Mariami

July 11, 2025
Explore No Deposit Casinos for Kiwis: A Complete Guide

Explore No Deposit Casinos for Kiwis: A Complete Guide

July 11, 2025
© Itay Kabalo

Essential Insights for Those Looking to Buy Vape Online

July 11, 2025
Just Beginning to Invest in Art? Here Are a Few Things to Do to Get Started

Just Beginning to Invest in Art? Here Are a Few Things to Do to Get Started

July 10, 2025
Craig Dempsey

Redefining Wellness Travel: A Conversation With Craig Dempsey of Medical Tourism Packages

July 10, 2025
How to Extend the Lifespan of Your Commercial Roof

How to Extend the Lifespan of Your Commercial Roof

July 10, 2025
The Importance of Defensive Driving and How It Can Save Your Life

The Importance of Defensive Driving and How It Can Save Your Life

July 10, 2025
Tips for Maintaining a Healthy Gut

Tips for Maintaining a Healthy Gut

July 10, 2025
Inside the High-Tech Tools Online Casinos Use to Keep Players Hooked

Inside the High-Tech Tools Online Casinos Use to Keep Players Hooked

July 10, 2025
iGaming Integration Services: Powering Seamless Online Game Experiences

iGaming Integration Services: Powering Seamless Online Game Experiences

July 10, 2025
No Result
View All Result

Headlines

Misconception Debunked: 5 Ways a Maxi Dress Can Bring Out Your Elegance

Estate Planning Essentials – Financial Planner D. Paterson Cope Shares Tips for Retirees

Toner Laser Printer vs Inkjet: Which Is Better for High-Volume Printing?

SEO Tips for Personal Injury Law Firms

The Business Case for Off-Grid Solar: Lower Costs, Higher Resilience

What Was Once Veiled Now Reigns by Mariami

Trending

Charleston Rings: Custom Engagement Rings Crafted With Faith and Innovation
Lifestyle

Charleston Rings: Custom Engagement Rings Crafted With Faith and Innovation

by Kenisha Lewis
July 12, 2025

As soon as someone decides to get engaged, they might become overwhelmed by the available options for...

Rebuilding Higher: A Call to Action for Flood-Resilient Housing in Texas by Umar Ali, Head of Owth and Mophet Construction

Rebuilding Higher: A Call to Action for Flood-Resilient Housing in Texas by Umar Ali, Head of Owth and Mophet Construction

July 12, 2025
Misconception Debunked: 5 Ways a Maxi Dress Can Bring Out Your Elegance

Misconception Debunked: 5 Ways a Maxi Dress Can Bring Out Your Elegance

July 11, 2025
Estate Planning Essentials - Financial Planner D. Paterson Cope Shares Tips for Retirees

Estate Planning Essentials – Financial Planner D. Paterson Cope Shares Tips for Retirees

July 11, 2025
Toner Laser Printer vs Inkjet: Which Is Better for High-Volume Printing?

Toner Laser Printer vs Inkjet: Which Is Better for High-Volume Printing?

July 11, 2025
  • Kia America представляет цены и захватывающие обновления для Sorento 2025 (ICE)

https://madisongraph.com/kia-america-unveils-pricing-and-exciting-updates-for-2025-sorento-ice/

#nyc #losangeles #chicago #houston #phoenix #philadelphia #sandiego #dallas #sanfrancisco #seattle #denver #washingtondc #boston #detroit #vancouver #toronto #publicrelations #marketingagency #earnedmedia #editorial #marketing #guestpost #guestposting #sponsored #sponsoredpost
  • Kia Recognized as One of TIME Magazine’s “World’s Most Sustainable Companies of 2024”

https://madisongraph.com/kia-recognized-as-one-of-time-magazines-worlds-most-sustainable-companies-of-2024/

#nyc #losangeles #chicago #houston #phoenix #philadelphia #sandiego #dallas #sanfrancisco #seattle #denver #washingtondc #boston #detroit #vancouver #toronto #publicrelations #marketingagency #earnedmedia #editorial #marketing #guestpost #guestposting #sponsored #sponsoredpost
  • VinFast Auto Establishes Dealer Advisory Board to Enhance Customer Experience

https://madisongraph.com/vinfast-auto-establishes-dealer-advisory-board-to-enhance-customer-experience/

#nyc #losangeles #chicago #houston #phoenix #philadelphia #sandiego #dallas #sanfrancisco #seattle #denver #washingtondc #boston #detroit #vancouver #toronto #publicrelations #marketingagency #earnedmedia #editorial #marketing #guestpost #guestposting #sponsored #sponsoredpost
  • Medicare Announces Expansion of Coverage for Microprocessor-Controlled Knees for Lower Mobility Users

https://lincolncitizen.com/medicare-announces-expansion-of-coverage-for-microprocessor-controlled-knees-for-lower-mobility-users/

#nyc #losangeles #chicago #houston #phoenix #philadelphia #sandiego #dallas #sanfrancisco #seattle #denver #washingtondc #boston #detroit #vancouver #toronto #publicrelations #marketingagency #earnedmedia #editorial #marketing #guestpost #guestposting #sponsored #sponsoredpost
  • GA-ASI Successfully Tests PT6 Engine on MQ-9B SkyGuardian Aircraft

https://lincolncitizen.com/ga-asi-successfully-tests-pt6-engine-on-mq-9b-skyguardian-aircraft/

#nyc #losangeles #chicago #houston #phoenix #philadelphia #sandiego #dallas #sanfrancisco #seattle #denver #washingtondc #boston #detroit #vancouver #toronto #publicrelations #marketingagency #earnedmedia #editorial #marketing #guestpost #guestposting #sponsored #sponsoredpost
  • U.S. Leading Economic Index Declines by 0.2% in June 2024, Coincident Index Rises by 0.3%

https://fairmontpost.com/u-s-leading-economic-index-declines-by-0-2-in-june-2024-coincident-index-rises-by-0-3/

#nyc #losangeles #chicago #houston #phoenix #philadelphia #sandiego #dallas #sanfrancisco #seattle #denver #washingtondc #boston #detroit #vancouver #toronto #publicrelations #marketingagency #earnedmedia #editorial #marketing #guestpost #guestposting #sponsored #sponsoredpost
  • USTDA Director Travels to Bulgaria and Romania to Promote Clean, Secure Energy

https://belmontstar.com/ustda-director-travels-to-bulgaria-and-romania-to-promote-clean-secure-energy/

#nyc #losangeles #chicago #houston #phoenix #philadelphia #sandiego #dallas #sanfrancisco #seattle #denver #washingtondc #boston #detroit #vancouver #toronto #publicrelations #marketingagency #earnedmedia #editorial #marketing #guestpost #guestposting #sponsored #sponsoredpost
  • Police Recommend a Hidden Camera Detector Device to Protect Privacy

https://marketsherald.com/police-recommend-a-hidden-camera-detector-device-to-protect-privacy/

#nyc #losangeles #chicago #houston #phoenix #philadelphia #sandiego #dallas #sanfrancisco #seattle #denver #washingtondc #boston #detroit #vancouver #toronto #publicrelations #marketingagency #earnedmedia #editorial #marketing #guestpost #guestposting #sponsored #sponsoredpost

© 2025 The Hudson Weekly. Published by The Ritz Herald. Editions: Markets Herald • Lincoln Citizen • Madison Graph • Belmont Star • Fairmont Post

Address: 1177 6th Avenue, 5th Floor, New York, NY 10036. Removals: pr@hudsonweekly.com. Phone: (718) 313-5252. M-F: 9AM-5PM. Privacy Policy

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

No Result
View All Result
  • Financial
  • Blockchain
  • Technology
  • Entertainment
  • Lifestyle
  • Arts
  • Health
  • Sports
  • Cybersecurity

© 2025. The Hudson Weekly